yuvrajkatkar
★    

Pune, Maharashtra (India),
2009-09-15 16:04
(5698 d 20:46 ago)

Posting: # 4207
Views: 10,102
 

 Bioequivalence study of Iron Sucrose Injection 20 mg/ml [Software]

Dear all,

I have some queries regarding the Bioequivalence study of a parenteral drug (Iron Sucrose Injection 20 mg/ml).

In this study 5 ml of 20 mg/ml injection will be administered undiluted as a slow intravenous injection through an indwelling cannula over a period of 5 minutes.

I need your guidance regarding the Non-compartmental model (IV bolus model or IV infusion model) to be used in WinNonlin for estimation of Pharmacokinetic Parameters which are mentioned below:
Primary Parameters: Cmax (ng/mL), AUC0-t (ng·hr/mL), AUC0-inf (ng·hr/mL)
Secondary Parameters: Tmax (min), Kel (hr-1), t1/2 (hr), Vc (L), Vss (L), CL (L/hr)

I would highly appreciate your response regarding the same


Edit: Category changed. [Helmut]

Best Regards,
Yuvraj
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2009-09-17 17:06
(5696 d 19:44 ago)

@ yuvrajkatkar
Posting: # 4211
Views: 8,090
 

 WinNonlin: RTFM ;-)

Dear Yuvraj,

see WinNonlin's User Guide > Noncompartmental Analysis > NCA model selection.

The appropriate model is #202 (Constant Infusion).
WinNonlin has some problems in dealing with unit conversions (dose only). I suggest to give the dose in the mass unit of the concentration (in your case 20,000,000 ng) and the length of infusion in hours (5 min = 0.083 h), time of last dose 0.

❝ Secondary Parameters: Tmax (min), [...] Vc (L), Vss (L), CL (L/hr)


If you want to get Tmax in minutes: Model options > Units. In the row 'Tmin, Tmax, Tlast, Tlag' change in the column 'Preferred' from 'hr' to 'min'. Note that units of these four parameters cannot be changed independently (in all versions including Phoenix WinNonlin 6). BTW, do you expect Tmax to be different from 5 min? In the same tab change volumes from mL to L and clearance from mL/hr to L/hr.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
yuvrajkatkar
★    

Pune, Maharashtra (India),
2009-09-18 10:37
(5696 d 02:13 ago)

(edited on 2009-09-18 12:42)
@ Helmut
Posting: # 4212
Views: 8,927
 

 Bioequivalence study of Iron Sucrose Injection 20 mg/ml

Dear Sir,

As per your Guidance, I have runned the Raw Data file.

I have got following parameters:
Tmax, Cmax, AUC, Vz_Obs, Vz_Pred, Vss_Obs, Vss_Pred, CL_Obs, CL_Pred.

But Sir, how to calculate Vc?
Is Vc or Vz_obs same?

I need your guidance.

Thanks and Best Regards,

Yuvraj

--
Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Jaime]

Best Regards,
Yuvraj
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2009-09-18 15:55
(5695 d 20:56 ago)

@ yuvrajkatkar
Posting: # 4216
Views: 8,438
 

 PK-basics / terminology issues

Dear Vuvraj!

❝ I have got following parameters:

❝ Tmax, Cmax, AUC, Vz_Obs, Vz_Pred, Vss_Obs, Vss_Pred, CL_Obs, CL_Pred.


You can’t learn pharmacokinetics from a webforum. I would strongly suggest to read textbooks on PK, get some training in PK, or – as a starter – have a look at David Bourne's excellent A First Course in Pharmacokinetics and Biopharmaceutics. It doesn’t make sense to click through a piece of specialized software without knowledge of the basics behind. Sorry, there are no shortcuts.

Again, RTFM! For NCA formulas see WinNonlin’s User's Guide > WinNonlin Model Libraries > Noncompartmental analysis > Plasma or serum data.

There’s no consensus on terminology in PK. This may sound strange more than 50 years after publication of the first textbook.1 That’s the reason many papers in the Journal of Pharmacokinetics and Pharmacodynamics still contain a section of abbreviations and definition of terms. ;-)

❝ [...] how to calculate Vc?

❝ Is Vc or Vz_obs same?


Vc is the Volume of the central compartment in a multi-compartment model used in textbooks e.g, Gibaldi/Perrier,2 Wagner,3 and more recently Gabrielsson/Weiner.4 WinNonlin uses the term V1 for the central and V2-3 for the first and second [sic] peripheral compartment(s). Unless your drug shows more than one segment in a semilog plot and you perform PK-modeling, you will not obtain Vc. Therefore in NCA you only get parameters based on the apparent elimination phase.

Even if Vc is used, the numbering of transfer rate constants still uses 1 for the central compartment:[2, p.49]

+-------------+  k12   +-------------+
|   Central   | ----→ | Peripheral  |
| Compartment | ←---- | Compartment |
+-------------+  k21   +-------------+
       |
       | k10
       ↓

Note: k12, k21, k10 (not kc2, k2c, kc0). The index 0 denotes ‘one-way-compartment’ of no defined volume. For extravasal administration the absorption rate constant is given as k01 (or ka), all elimination processes are denoted by ki0 (e.g., k10 from central or k20 from the first peripheral). In a one-compartment model elimination sometimes is also denoted as kel. All elimination processes may be composites of elimination of the parent drug and formation of metabolite(s). Unless you have metabolite data, you cannot distinguish between them. If multi-compartment models are concerned, there are many (!) different ones describing the data equally well (i.e., the same minimum SSQ, but different parameter values). Sampling from only the central compartment will give you no clue, which one is the “right” one. This problem is called model identifiability. You see, PK can be quite tricky. Therefore, if possible stick with NCA until you know what to do.

For PK formulas see WinNonlin’s User’s Guide > WinNonlin Model Libraries > Pharmacokinetic models >
  • Model 2 (infusion, 1 compartment),
  • Model 9 (infusion, 2 compartments),
  • Model 19 (infusion, 3 compartments).

    References:
  1. Dost FH. Der Blutspiegel: Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit. Leipzig: Thieme-Verlag; 1953 (in German).
  2. Gibaldi M, D Perrier D. Pharmacokinetics. New York: Marcel Dekker; 2nd ed. 1982 (reprint: New York: informa healthcare; 2007).
  3. Wagner JG. Pharmacokinetics for the Pharmaceutical Scientist. Lancaster: Technomic Publishing; 1993.
  4. Gabrielsson J, Weiner D. Pharmacokinetic & Pharmacodynamic Data Analysis: Concepts and Applications. Stockholm: Swedish Pharmaceutical Press; 4th edition 2006.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
23 visitors (0 registered, 23 guests [including 3 identified bots]).
Forum time: 12:51 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5